|
11 |
A Decision-Theoretic Framework for the Application of Cost-Effectiveness Analysis in Regulatory Processes
Enthalten in PharmacoEconomics Bd. 27, 17.9.2012, Nr. 8, date:8.2009: 645-655
|
|
|
|
12 |
A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data
Enthalten in PharmacoEconomics Bd. 29, 11.12.2012, Nr. 6, date:6.2011: 497-510
|
|
|
|
13 |
A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing
Enthalten in Applied health economics and health policy Bd. 10, 12.12.2012, Nr. 4, date:7.2012: 217-225
|
|
|
|
14 |
A Pharmacoepidemiological Network Model for Drug Safety Surveillance
Enthalten in Drug safety Bd. 35, 13.12.2012, Nr. 5, date:5.2012: 395-406
|
|
|
|
15 |
A Pharmacokinetic-Pharmacodynamic Model for Predicting the Impact of CYP2C9 and VKORC1 Polymorphisms on Fluindione and Acenocoumarol During Induction Therapy
Enthalten in Clinical pharmacokinetics Bd. 51, 13.9.2012, Nr. 1, date:1.2012: 41-53
|
|
|
|
16 |
A ‘Plane’ Explanation of Anterior Cruciate Ligament Injury Mechanisms
Enthalten in Sports medicine Bd. 40, 21.11.2012, Nr. 9, date:9.2010: 729-746
|
|
|
|
17 |
A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
Enthalten in PharmacoEconomics Bd. 28, 23.9.2012, Nr. 1, date:1.2010: 61-74
|
|
|
|
18 |
A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic Drugs
Enthalten in CNS drugs Bd. 24, 29.8.2012, Nr. 12, date:12.2010: 1055-1068
|
|
|
|
19 |
A Qualitative Study on Feasibility of a Web-Based Women’s Health Portal and Information System
Enthalten in The Patient Bd. 4, 24.8.2012, Nr. 1, date:1.2011: 67-68
|
|
|
|
20 |
A Reappraisal of Current Dosing Strategies for Intravenous Fosfomycin in Children and Neonates
Enthalten in Clinical pharmacokinetics Bd. 50, 13.9.2012, Nr. 8, date:8.2011: 493-503
|
|
Administration
